Description:

Traditional first line therapy for glaucoma treatment has historically been topical glaucoma medications, but with new studies supporting selective laser trabeculoplasty and the recent addition of glaucoma drug delivery to the market the debate has begun. This course will include three instructors, each taking a side, and debating the current literature on topical glaucoma medications vs SLT vs glaucoma drug delivery as first line therapy for our glaucoma patients.

Course Code:

AOA173-GL

Speaker(s):

Justin Schweitzer, O.D.
justin.schweitzer@vancethompsonvision.com

Walter Whitley, O.D.
wowhitley@gmail.com

Nathan Lighthizer, O.D.
lighthiz@nsuok.edu

Credits:

1

AOA Expiration Date:

8/27/2024

Related News

How the HIPAA Privacy Rule applies in a public health emergency

In response to Hurricane Ian, the federal government takes steps to ease the pains of disaster recovery in Florida. Learn more about the federal waivers—and how you can help colleagues affected by disaster.

AOA+ aims for new heights: 3,000 in DC for ’23

Learn more about AOA+ travel grant opportunities to attend this one-of-a-kind experience for optometry students, newly graduated doctors, and educators in Washington, D.C., June 21-24, 2023.

Partners in care

The AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.